M&A

Reckitt Benckiser Said to Have Edge for Merck OTC Unit
Bloomberg
Tue, 04/8/14 - 11:33 am
Reckitt Benckiser
Merck
OTC
M&A
Is There a Lesson to Be Learned in Mallinckrodt's Questcor Deal?
Motley Fool
Tue, 04/8/14 - 10:44 am
M&A
Questcor Pharmaceuticals
Mallinckrodt
FirstWord Lists – The Quarterly: 10 key pharma events that occurred in Q1
First Word Pharma
Mon, 04/7/14 - 10:24 am
immuno-oncology
Sovaldi
Gilead Sciences
Teva Pharmaceuticals
Copaxone
GSK
Breo Ellipta
Forest Labs
Actavis
M&A
Affordable Care Act
biosimilars
PCSK9 inhibitors
Mallinckrodt to buy Questcor in cash-and-shares deal
Marketwatch
Mon, 04/7/14 - 08:48 am
Mallinckrodt
Questcor
M&A
India’s Sun Pharma to Buy Ranbaxy in $3.2 Billion Deal
Bloomberg
Mon, 04/7/14 - 08:36 am
Sun Pharma
Ranbaxy
India
M&A
Nestle and Fresenius home in on Danone Medical - sources
Yahoo/Reuters
Fri, 04/4/14 - 09:34 am
Nestle
Fresenius
Danone
M&A
Generic drug maker Mylan may buy Swedish rival Meda
Yahoo/Reuters
Fri, 04/4/14 - 09:17 am
Meda
generics
Mylan
M&A
Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?
Motley Fool
Thu, 04/3/14 - 09:41 am
M&A
Ariad Pharmaceuticals
Eli Lilly
Iclusig
Jazz Pharmaceuticals
GSK
Baxter snaps up its hemophilia partner on the verge of a biotech breakup
Fierce Biotech
Thu, 04/3/14 - 09:32 am
hemophilia
Baxter International
M&A
Chatham Therapeutics
Sanofi eyes more acquisitions, sees growth in Africa
Yahoo/Reuters
Wed, 04/2/14 - 09:44 pm
Sanofi
Africa
M&A
Chris Viehbacher
Danone-Mead Johnson Would Make Baby Food Giant: Real M&A
Bloomberg
Wed, 04/2/14 - 07:33 am
Danone
Mead Johnson
infant nutrition
M&A
Actavis shells out $100M for Thai generics maker in bid for Southeast Asia growth
Fierce Pharma
Tue, 04/1/14 - 01:25 pm
Actavis
generics
M&A
Silom
Celgene doubles down on Forma with a $600M discovery deal tied to a buyout option
Fierce Biotech
Tue, 04/1/14 - 08:15 am
Celgene
Forma Therapeutics
drug discovery
M&A
$4B deal: J&J sells lab testing unit to Carlyle
USA Today
Mon, 03/31/14 - 09:36 am
JNJ
M&A
Carlyle
diagnostics
Ortho-Clinical Diagnostics
Zacks Industry Outlook Highlights: Eli Lilly, AstraZeneca, Shire, Salix and Cubist Pharmaceuticals
Yahoo/Zacks.com
Thu, 03/27/14 - 09:47 am
Eli Lilly
Shire
Salix
AstraZeneca
Cubist Pharmaceuticals
M&A
Baxter explores sale of its vaccines business: sources
Yahoo/Reuters
Wed, 03/26/14 - 03:30 pm
Baxter International
M&A
vaccines
AstraZeneca takes control of its destiny in Japan with buyout; drugmaker snatches up Sumitomo and gets Forxiga approval there
Fierce Pharma
Wed, 03/26/14 - 01:06 pm
M&A
Japan
Forixga
Dainippon Sumitomo
AstraZeneca
Sanofi Said to Join Bidders for Merck’s Consumer-Health Business
Bloomberg
Mon, 03/24/14 - 06:21 pm
Sanofi
Merck
M&A
consumer health
Did Endocyte Just Become Buyout Bait?
Wall St 24/7
Fri, 03/21/14 - 10:39 am
Endocyte
M&A
Merck
vintafolide
Valeant Targets Corporate ‘Fat’ in Push for Big Leagues
Bloomberg
Thu, 03/20/14 - 09:31 am
Valeant Pharmaceuticals
Mike Pearson
restructuring
Bausch & Lomb
M&A

Pages